Zobrazeno 1 - 10
of 282
pro vyhledávání: '"Elihu Estey"'
Autor:
Laura Cicconi, Anna Maria Testi, Pau Montesinos, Eduardo Rego, Hong Hu Zhu, Hiroyuki Takahashi, Michael Dworzak, Elihu Estey, Anthony Schwarer, Jordi Esteve, Ombretta Annibali, Roberto Castelli, Milena Mirabile, Mario Angelini, Vladimir Lazarevic, Jeevan Kumar, Giuseppe Avvisati, Carmelo Gurnari, Franco Locatelli, Maria Teresa Voso, Miguel Angel Sanz, Francesco Lo-Coco, Oussama Abla
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/952825a19cbd4a4cadc9a98a15926e56
Autor:
Clara D. Bloomfield, Guido Marcucci
Publikováno v:
New England Journal of Medicine. 360:313-313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eeadcd483045babaa1a7c0c0133564a
https://doi.org/10.1056/nejmbkrev0805093
https://doi.org/10.1056/nejmbkrev0805093
Autor:
Johann Hitzler, Elihu Estey
Publikováno v:
Haematologica, Vol 104, Iss 1 (2019)
Externí odkaz:
https://doaj.org/article/a74ec890057a402c8ffc71815ecef259
Autor:
Maher Albitar, Francis Giles, Michael Keating, Jorge Cortes, Zeev Estrov, Elihu Estey, Susan O'Brien, Zhong J. Zhang, Xi Zhang, Amber C. Donahue, Benjamin Bekele, Hagop Kantarjian, Wanlong Ma
Purpose: Cytogenetic abnormalities are currently the most important predictors of response and clinical outcome for patients with acute myeloid leukemia (AML) or advanced-stage myelodysplastic syndrome (MDS). Because clinical outcomes vary markedly w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f9a71c46b0fc1335d27e5216c074be
https://doi.org/10.1158/1078-0432.c.6517486.v1
https://doi.org/10.1158/1078-0432.c.6517486.v1
Autor:
Jean-Pierre J. Issa, Guillermo Garcia-Manero, Hagop Kantarjian, Elihu Estey, Kazuo Konishi, Vazganush Gharibyan, Lanlan Shen, Xuqi Chen, Yutaka Kondo, Yanis A. Boumber
Gene silencing associated with promoter methylation can inactivate tumor suppressor genes (TSG) in cancer. We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7872cd95bf485fe2d34f01f892c9bcc3
https://doi.org/10.1158/0008-5472.c.6495164
https://doi.org/10.1158/0008-5472.c.6495164
Autor:
Jean-Pierre J. Issa, Guillermo Garcia-Manero, Hagop Kantarjian, Elihu Estey, Kazuo Konishi, Vazganush Gharibyan, Lanlan Shen, Xuqi Chen, Yutaka Kondo, Yanis A. Boumber
Supplementary Table 1 from RIL, a LIM Gene on 5q31, Is Silenced by Methylation in Cancer and Sensitizes Cancer Cells to Apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5bbd90980d7e2071e128205ff23100
https://doi.org/10.1158/0008-5472.22366496.v1
https://doi.org/10.1158/0008-5472.22366496.v1
Autor:
Mohamed Lotfy, Sorror, Ted A, Gooley, Barry E, Storer, Aaron T, Gerds, Mikkael A, Sekeres, Bruno C, Medeiros, Eunice S, Wang, Paul J, Shami, Kehinde U A, Adekola, Selina M, Luger, Maria R, Baer, David A, Rizzieri, Tanya, Wildes, Jamie, Koprivnikar, Julie, Smith, Mitchell, Garrison, Kiarash, Kojouri, Tammy A, Schuler, Wendy M, Leisenring, Lynn, Onstad, Pamela S, Becker, Jeannine S, McCune, Stephanie J, Lee, Brenda M, Sandmaier, Frederick R, Appelbaum, Elihu, Estey
Publikováno v:
Blood.
We designed a prospective, observational study enrolling patients presenting for treatment of AML at 13 institutions to analyze associations between hematopoietic cell transplantation (HCT) and survival, quality of life (QOL), function and geriatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c8eca021645cc579d68e5aa1a98d5831
https://pubmed.ncbi.nlm.nih.gov/36260765
https://pubmed.ncbi.nlm.nih.gov/36260765
Autor:
Megan Othus, Wim van Putten, Bob Lowenberg, Stephen H. Petersdorf, Sucha Nand, Harry Erba, Frederick Appelbaum, Robert Hills, Nigel Russell, Alan Burnett, Elihu Estey
Publikováno v:
Haematologica, Vol 101, Iss 7 (2016)
Externí odkaz:
https://doaj.org/article/65d96c3113124264b2e5d631f352f7b8
Autor:
Colin Godwin, Eduardo Rodríguez-Arbolí, Megan Othus, Anna Halpern, Jacob Appelbaum, Mary-Elizabeth Percival, Paul Hendrie, Vivian Oehler, Siobán Keel, Janis Abkowitz, Jason Cooper, Ryan Cassaday, Elihu Estey, Roland Walter
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2934
Gemtuzumab ozogamicin (GO) improves outcomes when added to intensive AML chemotherapy. A meta-analysis suggested the greatest benefit when combining fractionated doses of GO (GO3) with 7 + 3. To test whether GO3 can be safely used with high intensity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e204500614f954a913270746c4300a8
https://doi.org/10.3390/cancers14122934
https://doi.org/10.3390/cancers14122934
Autor:
Elihu Estey
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 5, Iss 1, Pp e2013050-e2013050 (2013)
Although “less intense” therapies are finding more use in AML, the principal problem in AML remains lack of efficacy rather than toxicity. Hence less intense therapies are of little use if they are not more effective as well as less toxic than st
Externí odkaz:
https://doaj.org/article/14b77e65b99d41a9bc1d9a08dd9a86d7